Health

NAFDAC Issues Warning on Recalled High-Caffeine G Fuel Energy Drinks

Pinterest LinkedIn Tumblr
NAFDAC Issues Warning on Recalled High-Caffeine G Fuel Energy Drinks
NAFDAC Notifies Public About G Fuel Energy Drinks Recall

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert, warning the public about the G Fuel brand Energy Drinks, which have been recalled due to their high caffeine content. The alert, numbered 034/2023, was released in Abuja on Thursday by NAFDAC’s Director-General, Prof Mojisola Adeyeye.

Adeyeye disclosed that NAFDAC was made aware of the product recall by T&E Imports and GPAE Trading Corp, following notifications from the Netherlands Food and Consumer Product Safety Authority (NVWA) and the Canadian Food Inspection Agency (CFIA).

Emphasizing the potential health risks associated with consuming high levels of caffeine, Adeyeye cautioned that individuals may experience symptoms such as headaches, insomnia, irritability, and nervousness, especially if they are sensitive to caffeine. Pregnant women were also advised against consuming these products, as excessive caffeine intake could lead to an increased risk of miscarriage and low birth weight.

Adeyeye further noted that the recalled products lack proper cautionary statements limiting the number of servings per day and are available for purchase online. Importantly, she pointed out that these products have not been registered by NAFDAC, urging both consumers and retailers to refrain from using, selling, serving, or distributing the implicated products.

To report any suspicion of the distribution and sale of unwholesome packaged food products, the public is encouraged to contact the nearest NAFDAC office or reach out to NAFDAC at 0800-162-3322 or via email at sf.alert@nafdac.gov.ng. Healthcare professionals and patients are also urged to report adverse events or side effects related to the use of any substandard NAFDAC-regulated product, utilizing the E-reporting platforms available on the NAFDAC website (www.nafdac.gov.ng) or the Med-safety application, which can be downloaded from Android and IOS stores. Additionally, NAFDAC can be reached via email at pharmacovigilance@nafdac.gov.ng.

Comments are closed.

Exit mobile version